Skip to main content
. 2021 Jun 30;8(2):137–144. doi: 10.15441/ceem.21.008

Table 1.

Comparison of general and resuscitative characteristics of OHCA patients

Total (n=297) Control period (n=145) Study period (n=152) P-value
Age (yr) 76.0 (64.0–82.0) 74.0 (61.5–82.0) 76.0 (66.0–81.8) 0.159
Sex 0.432
 Male 193 (65.0) 91 (62.8) 102 (67.1)
 Female 104 (35.0) 54 (37.2) 50 (32.9)
Comorbidities 251 (84.5) 124 (85.5) 127 (83.6) 0.640
 Hypertension 119 (47.4) 58 (46.8) 61 (48.0) 0.842
 Diabetes mellitus 98 (39.0) 52 (41.9) 46 (36.2) 0.353
 Ischemic heart disease 46 (18.3) 22 (17.7) 24 (18.9) 0.813
 Stroke 31 (12.4) 9 (7.3) 22 (17.3) 0.015
Location 0.170
 Home 239 (80.5) 112 (77.2) 127 (83.6)
 Public place 58 (19.5) 33 (22.8) 25 (16.4)
Dispatcher recognition 0.604
 Yes 213 (71.7) 106 (73.1) 107 (70.4)
 No 84 (28.3) 39 (26.9) 45 (29.6)
Witnessed arrest 0.740
 Yes 134 (45.1) 64 (44.1) 70 (46.1)
 No 163 (54.9) 81 (55.9) 82 (53.9)
Bystander CPR 0.444
 Yes 186 (62.6) 94 (64.8) 92 (60.5)
  Before dispatcher instruction 58 (31.2) 35 (37.2) 23 (25.0)
  After dispatcher instruction 128 (68.8) 59 (62.8) 69 (75.0)
 No 111 (37.4) 51 (35.2) 60 (39.5)
Use of public-access AED by bystander 1.000
 Yes 4 (1.3) 2 (1.4) 2 (1.3)
 No 293 (98.7) 143 (98.6) 150 (98.7)
First documented rhythm 0.095
 VF/pVT 44 (14.8) 24 (16.6) 20 (13.2)
 PEA 61 (20.5) 36 (24.8) 25 (16.4)
 Asystole 192 (64.6) 85 (58.6) 107 (70.4)
Prehospital IV epinephrine use 0.639
 Yes 127 (42.8) 64 (44.1) 63 (41.4)
 No 170 (57.2) 81 (55.9) 89 (58.6)
Response time (min) 7.0 (5.0–9.0) 6.0 (5.0–7.0) 8.0 (7.0–11.0) < 0.001
On-scene time (min) 19.0 (15.0–22.0) 17.0 (14.0–20.5) 19.0 (17.0–23.0) < 0.001
Transport time (min) 7.0 (4.0–10.0) 7.0 (4.0–11.0) 7.0 (4.0–10.0) 0.163
First defibrillation time (min) 9.0 (7.25–11.0) 8.0 (7.0–9.0) 11.0 (10.0–13.5) < 0.001

Values are presented as median (interquartile range) or number (%).

OHCA, out-of-hospital cardiac arrest; CPR, cardiopulmonary resuscitation; AED, automated external defibrillator; VF, ventricular fibrillation; pVT, pulseless ventricular tachycardia; PEA, pulseless electrical activity; IV, intravenous.